Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Immunity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03630809
What this trial is testing

Immune Response and Potential Booster for Patients Who Have Received HER2-pulsed DC1

Who this might be right for
Breast CancerHER2-positive Breast CancerHER-2 Gene Amplification+4 more
H. Lee Moffitt Cancer Center and Research Institute 16
Not applicableUnknownNCT02243163
What this trial is testing

Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or Chemotherapy

Who this might be right for
Female Breast Carcinoma
Chang Bing Show Chwan Memorial Hospital 40
Not applicableStudy completedNCT03383107
What this trial is testing

Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome

Who this might be right for
Breast CancerProstate Cancer
Weill Medical College of Cornell University 66
Not applicableLooking for participantsNCT04363983
What this trial is testing

Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms

Who this might be right for
Gastrointestinal Neoplasms
Assistance Publique - Hôpitaux de Paris 6,300
Not applicableStudy completedNCT03422120
What this trial is testing

Human Blood Specimen Collection to Evaluate Immune Cell Function

Who this might be right for
Colorectal CancerSurgeryPerioperative Care
Ottawa Hospital Research Institute 69
Very early researchStudy completedNCT04936997
What this trial is testing

Immune Response to the COVID-19 Vaccine

Who this might be right for
Covid19CancerMalignancy+1 more
University of Arizona 20
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Not applicableEnded earlyNCT00289146
What this trial is testing

Comparison of Immune Response Following Surgical Management of Renal Tumors

Who this might be right for
Kidney Cancer
Emory University 50
Not applicableLooking for participantsNCT07564219
What this trial is testing

BEAM-MM - β-Hydroxybutyrate-Enhanced Adaptive Immunity in Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)CAR T CellsBispecific Antibodies
Universitätsklinikum Hamburg-Eppendorf 45
Not applicableUnknownNCT01198808
What this trial is testing

Tumorspecific T-cell Immunity in Bladder Cancer as Prognostic Marker

Who this might be right for
Bladder Cancer
Technical University of Munich 50
Early research (Phase 1)Study completedNCT05238558
What this trial is testing

Safety and Immune Response to FMPV-1

Who this might be right for
Colorectal Cancer
Hubro Therapeutics AS 16
Testing effectiveness (Phase 2)Study completedNCT00319748
What this trial is testing

Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer+1 more
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Testing effectiveness (Phase 2)Ended earlyNCT04364178
What this trial is testing

Viral Specific T-Lymphocytes to Treat Adenovirus, CMV and EBV

Who this might be right for
AdenovirusCytomegalovirus InfectionsEpstein-Barr Virus
Jessie L. Alexander, MD 8
Not applicableNot Yet RecruitingNCT07648810
What this trial is testing

Comparison Immune Response in Paravertebral and Erector Spinal Plane Block in Breast Cancer Patients

Who this might be right for
Breast Cancer - Female
Clinical Hospital Center Rijeka 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05232851
What this trial is testing

A Vaccine (PDS0101) Alone or in Combination With Pembrolizumab for the Treatment of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus-Related CarcinomaLocally Advanced Oropharyngeal Carcinoma+2 more
Mayo Clinic 20
Not applicableEnded earlyNCT04852822
What this trial is testing

Immune Response to SARS-CoV-2 (COVID-19) Vaccines in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
University of Washington 350
Not applicableStudy completedNCT00979381
What this trial is testing

Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor

Who this might be right for
Renal Cell CarcinomaGIST
Radboud University Medical Center 75
Not applicableStudy completedNCT00653146
What this trial is testing

The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia

Who this might be right for
Cervical CancerPrecancerous Condition
Fox Chase Cancer Center 186
Next Page